Arecor Therapeutics (AREC) Stock Chart & Stock Price History GBX 67 -2.50 (-3.60%) (As of 12/20/2024 06:45 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Arecor Therapeutics Stock Price Performance 5 Day Performance-0.04%1 Month Performance-10.67%3 Month Performance-2.19%6 Month Performance-44.17%Year-To-Date Performance-63.29%1 Year Performance-63.37% Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. AREC Stock Chart for Sunday, December, 22, 2024 AREC Chart by TradingView Arecor Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 68.55GBX 67-2.26%GBX 69.50GBX 6725,000 shs£25.30 million12/19/2024GBX 70GBX 68.55-2.07%GBX 69.50GBX 68.5515,214 shs£25.88 million12/18/2024GBX 67.03GBX 70+4.43%GBX 70GBX 68.5015,787 shs£26.43 million12/17/2024GBX 70GBX 67.03-4.24%GBX 70GBX 67.03829 shs£25.31 million12/16/2024GBX 70.50GBX 70-0.71%GBX 70GBX 67.302,431 shs£26.43 million12/13/2024GBX 76.50GBX 70.50-7.84%GBX 76.50GBX 64.5018,864 shs£26.62 million Get the Latest News and Ratings for AREC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 76.50GBX 76.50GBX 76.50GBX 75.063,000 shs£28.89 million12/11/2024GBX 76.50GBX 76.50GBX 76.50GBX 75.06741 shs£28.89 million12/10/2024GBX 75.06GBX 76.50+1.92%GBX 76.50GBX 75.061,000 shs£28.89 million12/09/2024GBX 75.06GBX 75.06GBX 75.64GBX 75.062,830 shs£28.34 million12/06/2024GBX 76.50GBX 75.06-1.88%GBX 76.50GBX 75.06690 shs£28.34 million12/05/2024GBX 76.50GBX 76.50GBX 76.50GBX 75.061,000 shs£28.89 million12/04/2024GBX 75.06GBX 76.50+1.92%GBX 78GBX 75.063,725 shs£28.89 million12/03/2024GBX 75GBX 75.06+0.08%GBX 78GBX 75.063,725 shs£28.34 million12/02/2024GBX 76.50GBX 75-1.96%GBX 76.50GBX 751,590 shs£28.32 million11/29/2024GBX 75GBX 75.74+0.99%GBX 76.50GBX 75.742,317 shs£28.60 million11/28/2024GBX 75.98GBX 75-1.29%GBX 78GBX 755,808 shs£28.32 million11/27/2024GBX 75GBX 75.98+1.31%GBX 76.50GBX 75.98263 shs£28.69 million11/26/2024GBX 76.50GBX 75-1.96%GBX 76.50GBX 75706 shs£28.32 million11/25/2024GBX 75GBX 76.50+2.00%GBX 76.50GBX 75371 shs£28.89 million11/22/2024GBX 76.50GBX 75-1.96%GBX 76GBX 75371 shs£28.32 million11/21/2024GBX 76.50GBX 76.50GBX 78GBX 73.50805 shs£28.89 million Related Companies Futura Medical Stock Price Chart Scancell Stock Price Chart SkinBioTherapeutics Stock Price Chart Tissue Regenix Group Stock Price Chart Poolbeg Pharma Stock Price Chart Sareum Stock Price Chart OptiBiotix Health Stock Price Chart Ondine Biomedical Stock Price Chart NetScientific Stock Price Chart Oncimmune Stock Price Chart Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AREC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
